Histamine and Bradykinin Pharmacology  ·  Module 1

Histamine Biology, Receptors, and Physiological Roles

Storage sites, receptor subtypes, signaling, and pathophysiological roles

Storage Sites

Immune

Mast Cells

  • Skin, airways, gut mucosa
  • Largest peripheral reservoir
  • IgE-mediated degranulation

Immune

Basophils

  • Circulating granulocytes
  • IgE-mediated release
  • Contribute to late-phase reactions

Gastric Mucosa

ECL Cells

  • Oxyntic gastric mucosa
  • Stimulated by gastrin and acetylcholine
  • Paracrine H2 activation of parietal cells

CNS

Histaminergic Neurons

  • Tuberomammillary nucleus
  • Promote wakefulness via H1
  • H1 blockade → sedation

Receptor Subtypes

ReceptorG ProteinKey LocationPrimary EffectDrug Target
H1GqVascular endothelium, bronchial smooth muscle, sensory neurons, central nervous systemVasodilation, increased permeability, bronchoconstriction, pruritus, wakefulnessH1 antihistamines (first- and second-generation)
H2GsGastric parietal cellsCyclic adenosine monophosphate → proton pump → acid secretionH2 blockers (cimetidine, famotidine)
H3GiPresynaptic neurons, central nervous systemInhibits histamine synthesis and release (autoreceptor)Pitolisant (narcolepsy)
H4GiImmune cellsEosinophil chemotaxis, immune modulationNo approved Step 1-level drug

Pathophysiological Roles

Skin — H1

Triple Response of Lewis

  • Redness: local arteriolar vasodilation
  • Wheal: plasma extravasation, increased vascular permeability
  • Flare: axon reflex — surrounding erythema
  • Itch: sensory C fiber H1 activation

Systemic

Anaphylaxis

  • Histamine: primary mediator of urticaria, angioedema, flushing
  • Multimediator: prostaglandins, leukotrienes, platelet-activating factor also released
  • Antihistamines are adjuncts only — do not reverse bronchospasm or hemodynamic collapse
  • Epinephrine is the only first-line treatment

High-Yield Rule — Angioedema Without Urticaria

Histamine-mediated angioedema occurs with urticaria. Bradykinin-mediated angioedema (hereditary angioedema, angiotensin converting enzyme inhibitor-induced) occurs without urticaria and does not respond to antihistamines, corticosteroids, or epinephrine. Requires bradykinin-specific therapy. See Module 4.